A major advance in cancer study is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This crucial malignant suppressor protein is frequently inactivated in several forms of cancer, leading https://bookmarkpath.com/story21926459/nanobodies-restore-tumor-suppressor-p53-the-new-hope-for-malignant-treatment